Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease
Condition(s):Sickle Cell DiseaseLast Updated:January 2, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:January 2, 2024Completed
Condition(s):Sickle Cell Disease; Sickle Cell-Beta0-ThalassemiaLast Updated:January 11, 2021Withdrawn
Condition(s):COVID-19Last Updated:August 23, 2021Unknown status
Condition(s):Thromboembolism of Vein VTE in Colorectal Cancer; Thromboembolism of Vein in Pancreatic Cancer; Thromboembolism of Vein in Non-small Cell Lung CancerLast Updated:March 3, 2021Completed
Condition(s):SARS-CoV 2; COVID-19; Coronavirus Disease 2019Last Updated:February 6, 2023Recruiting
Condition(s):Covid19Last Updated:February 5, 2021Unknown status
Condition(s):HealthyLast Updated:October 12, 2020Completed
Condition(s):Renal Cell Carcinoma; Kidney CancerLast Updated:January 18, 2017Unknown status
Condition(s):Cardiovascular DiseaseLast Updated:November 29, 2016Withdrawn
Condition(s):Chronic Kidney DiseaseLast Updated:April 20, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.